Abstract
Objectives
11C-Doxepin is an established positron emission tomography (PET) probe for imaging the histamine H1 receptor, which is associated with various neurological disorders and allergic diseases. A fully automated current Good Manufacturing Practices (cGMP)-compliant radiosynthesis is therefore desirable in order to facilitate clinical PET studies. We report here a fully automated production method for 11C-doxepin using a multipurpose PET module for clinical use.
Methods
11C-Doxepin was radiosynthesized by N-[11C]methylation of nordoxepin using [11C]methyl iodide in DMF solvent, and then purified by HPLC, and finally reformulated with solid phase extraction (SPE) using a cGMP-compliant automated multipurpose PET module developed in house. The final product was analyzed and subjected to quality control according to current US Pharmacopeia requirements.
Results
The radiochemical yield (decay corrected) of 11C-doxepin for clinical use was 47.0 ± 5.2% (n = 12) based on [11C]methyl iodide, moreover the radiochemical purity of 11C-doxepin was more than 97.5% with 1,200 ± 500 Ci/mmol specific activity(end of production). The total production time of 11C-doxepin was 37 min from end of bombardment (EOB) with the final product passing all tests under cGMP requirements for clinical use.
Conclusions
A simplified and reliable fully automated production of 11 C-doxepin for clinical use was developed, allowing the synthesis of the tracer with high yield using a cGMP-compliant module and procedure. The success of this approach could make the PET tracer 11 C-doxepin more accessible for clinical studies.
References
Passani MB, Blandina P (2011) Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol Sci 32(4):242–249
Jones BL, Kearns GL (2011) Histamine: new thoughts about a familiar mediator. Clin Pharmacol Ther 89(2):189–197
Tashiro M, Mochizuki H, Iwabuchi K, Sakurada Y, Itoh M, Watanabe T et al (2002) Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci 72(4–5):409–414
Singh H, Becker PM (2007) Novel therapeutic usage of low-dose doxepin hydrochloride. Expert Opin Investig Drugs 16(8):1295–1305
Pinder RM, Brogden RN, Speight TM, Avery GS (1977) Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression. Drugs 13(3):161–218
Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V et al (2011) Structure of the human histamine H1 receptor complex with doxepin. Nature 475:65–70
Tashiro M, Kato M, Miyake M, Watanuki S, Funaki Y, Ishikawa Y et al (2009) Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11 C]doxepin. Hum Psychopharmacol 24(7):540–548
Yanai K, Watanabe T, Yokoyama H, Meguro K, Hatazawa J, Itoh M et al (1992) Histamine H1 receptors in human brain visualized in vivo by [11 C]doxepin and positron emission tomography. Neurosci Lett 137(2):145–148
Van Ruitenbeek P, Vermeeren A, Riedel WJ (2010) Cognitive domains affected by histamine H(1)-antagonism in humans: a literature review. Brain Res Rev 64(2):263–282
Benarroch EE (2010) Histamine in the CNS: multiple functions and potential neurologic implications. Neurology 75(16):1472–1479
Higuchi M, Yanai K, Okamura N, Meguro K, Arai H, Itoh M et al (2000) Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 99(4):721–729
Iwabuchi K, Ito C, Tashiro M, Kato M, Kano M, Itoh M et al (2005) Histamine H1 receptors in schizophrenic patients measured by positron emission tomography. Eur Neuropsychopharmacol 15(2):185–191
Smith DF, Jakobsen S (2009) Molecular tools for assessing human depression by positron emission tomography. Eur Neuropsychopharmacol 19(9):611–628
Iinuma K, Yokoyama H, Otsuki T, Yanai K, Watanabe T, Ido T et al (1993) Histamine H1 receptors in complex partial seizures. Lancet 341(8839):238
Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M et al (2004) Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11 C-doxepin positron emission tomography. J Clin Pharmacol 44(8):890–900
Tashiro M, Duan X, Kato M, Miyake M, Watanuki S, Ishikawa Y et al (2008) Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11 C-doxepin. Br J Clin Pharmacol 65(6):811–821
Senda M, Kubo N, Adachi K, Ikari Y, Matsumoto K, Shimizu K et al (2009) Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine. J Nucl Med 50(6):887–892
Yun Z, Offord S, Dogan AS, Crabb AH, Wong DF (2002) Evaluation of antihistamine drugs by human [11 C]doxepin dynamic PET studies with a parametric image approach. Nuclear Science Symposium Conference Record, IEEE
Ravert HT, Dannals RF, Wilson AA, Wagner HN (1992) (N-[C-11]-Methyl) doxepin — synthesis of a radiotracer for studying the histamine H-1 receptor. J Label Compd Rad 31(5):403–407
Iwata R, Pascali C, Bogni A, Yanai K, Kato M, Ido T et al (2002) A combined loop-SPE method for the automated preparation of [C-11]doxepin. J Label Compd Rad 45(4):271–280
Chakraborty PK, Mangner TJ, Chugani DC, Muzik O, Chugani HT (1996) A high-yield and simplified procedure for the synthesis of alpha-[11 C]methyl-l-tryptophan. Nucl Med Biol 23(8):1005–1008
Mangner TJ, Klecker RW, Anderson L, Shields AF (2003) Synthesis of 2′-deoxy-2′-[18 F]fluoro-beta-d-arabinofuranosyl nucleosides, [18 F]FAU, [18 F]FMAU, [18 F]FBAU and [18 F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18 F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol 30(3):215–224
Li Z, Conti PS (2010) Radiopharmaceutical chemistry for positron emission tomography. Adv Drug Deliv Rev 62(11):1031–1051
Lemaire C, Plenevaux A, Aerts J, Del Fiore G, Brihaye C, Le Bars D et al (1999) Solid phase extraction — an alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticals. J Label Compd Rad 42(1):63–75
Krasikova R (2007) Synthesis modules and automation in F-18 labeling. Ernst Schering Res Found Workshop 62:289–316
Acknowledgements
We would like to thank the staff members of the Children's Hospital of Michigan PET center for their service and support.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cai, H., Mangner, T.J., Muzik, O. et al. Fully Automated Production of 11C-Doxepin for PET Imaging Histamine H1 Receptor. Mol Imaging Biol 14, 546–552 (2012). https://doi.org/10.1007/s11307-011-0535-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-011-0535-x